COPD诊断后启动规律中高强度身体活动与死亡率的关联:基于全国队列数据的目标试验模拟
该研究采用目标试验模拟方法,纳入2010至2018年间诊断COPD前未进行中高强度身体活动(MVPA)且诊断前后各至少一次健康筛查的40岁以上患者。结果显示,诊断后启动MVPA与全因死亡风险(aHR 0.84,95%CI 0.79-0.89)及重度急性加重风险(aHR 0.90,95%CI 0.87-0.94)降低相关。
要点
- 启动MVPA亦与重度急性加重风险降低10%相关(aHR 0.90)。
- 年龄>65岁、女性、从不吸烟及合并症评分较高者获益更明显。
核心结论
- COPD诊断后启动MVPA可能降低死亡率和重度急性加重风险,但仍需个体化干预和进一步临床试验验证。
主要发现
- MVPA组相比对照组全因死亡调整风险比为0.84(95%CI 0.79-0.89)。
- MVPA组相比对照组重度急性加重完全调整风险比为0.90(95%CI 0.87-0.94)。
关键数值与推荐
- MVPA定义为每周≥3天每天进行>20分钟剧烈有氧运动,或每周≥5天每天进行>30分钟中等强度有氧运动。
- 主要终点为全因死亡率,次要终点为COPD诊断后首次重度急性加重时间。
临床怎么用
- 对COPD诊断前缺乏MVPA的患者,可考虑鼓励启动规律中高强度身体活动以降低死亡和重度急性加重风险。
- 对年龄>65岁、女性、从不吸烟及合并症较多的患者,MVPA的获益可能更明显,应加强个体化运动建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Moderate to vigorous physical activity (MVPA) in patients with COPD affects their overall health outcomes, including symptom relief and improved quality of life. However, the magnitude of the effect of MVPA initiation on real-world clinical outcomes has not been well investigated. RESEARCH QUESTION: How does MVPA initiation affect mortality and severe exacerbation in patients who have not engaged in MVPA prior to COPD diagnosis? STUDY DESIGN AND METHODS: This study included patients with COPD aged ≥ 40 years who were not performing MVPA prior to COPD diagnosis and who had at least one health screening visit prior to and following their COPD diagnosis between January 1, 2010, and December 31, 2018. The main exposure was MVPA, defined as vigorous aerobic exercise > 20 min per day on ≥ 3 days per week or moderate aerobic exercise > 30 min per day on ≥ 5 days per week. The primary end point was all-cause mortality, and the secondary end point was initial severe exacerbation as the time to event following COPD diagnosis. RESULTS: In total, 110,097 person-trials were included (27,564 MVPA increases and 82,533 control groups). No differences were observed between the covariates following matching. The adjusted hazards ratio of all-cause mortality for the MVPA group compared with the control group was 0.84 (95% CI, 0.79-0.89). In the subgroup analysis, patients aged > 65 years, female patients, those who had never smoked, and patients with a higher Charlson Comorbidity Index score displayed a stronger effect of MVPA on reducing mortality than younger male patients, those who had ever smoked, and patients with a lower Charlson Comorbidity Index score (Pinteraction < .05). The fully adjusted hazards ratio for the risk of severe exacerbation (MVPA group vs control) was 0.90 (95% CI, 0.87-0.94). INTERPRETATION: Initiation of MVPA can potentially reduce mortality and severe exacerbations in patients with COPD, although personalized interventions and further clinical trials are necessary.
引用
- Kim, Kim, Kong, et al. Association Between Regular Moderate to Vigorous Physical Activity Initiation Following COPD Diagnosis and Mortality: An Emulated Target Trial Using Nationwide Cohort Data. Chest. 2023. PMID: 37494977. doi:10.1016/j.chest.2023.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。